Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:52 pm Purchase | 2024-12-31 | 13G | Momentus Inc. MNTS | ARMISTICE CAPITAL LLC | 179,458 9.990% | 179,458 (New Position) | Filing History |
| 2025-02-14 5:52 pm Purchase | 2024-12-31 | 13G | MacroGenics, Inc. MGNX | ARMISTICE CAPITAL LLC | 6,276,000 9.990% | 18,000 (+0.29%) | Filing History |
| 2025-02-14 5:51 pm Purchase | 2024-12-31 | 13G | Moleculin Biotech, Inc. MBRX | ARMISTICE CAPITAL LLC | 339,767 9.990% | 38,779 (+12.88%) | Filing History |
| 2025-02-14 5:50 pm Purchase | 2024-12-31 | 13G | LM Funding America, Inc. LMFA | ARMISTICE CAPITAL LLC | 404,151 9.990% | 106,811 (+35.92%) | Filing History |
| 2025-02-14 5:50 pm Purchase | 2024-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | ARMISTICE CAPITAL LLC | 133,787 9.990% | 17,907 (+15.45%) | Filing History |
| 2025-02-14 5:49 pm Purchase | 2024-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | ARMISTICE CAPITAL LLC | 9,468,000 5.920% | 1,268,000 (+15.46%) | Filing History |
| 2025-02-14 5:49 pm Unchanged | 2024-12-31 | 13G | FibroGen, Inc. FGEN | ARMISTICE CAPITAL LLC | 6,800,000 6.750% | 0 (Unchanged) | Filing History |
| 2025-02-14 5:44 pm Sale | 2024-12-31 | 13G | 5E Advanced Materials Inc. FEAM | ARMISTICE CAPITAL LLC | 174,208 5.820% | -42,314 (-19.54%) | Filing History |
| 2025-02-14 5:44 pm Purchase | 2024-12-31 | 13G | Evaxion Biotech A/S EVAX | ARMISTICE CAPITAL LLC | 639,329 9.990% | 639,329 (New Position) | Filing History |
| 2025-02-14 5:44 pm Purchase | 2024-12-31 | 13G | Sphere 3D Corp. ANY | ARMISTICE CAPITAL LLC | 2,583,718 9.990% | 2,583,718 (New Position) | Filing History |
| 2025-02-14 5:43 pm Purchase | 2024-12-31 | 13G | Enlivex Therapeutics Ltd. ENLV | ARMISTICE CAPITAL LLC | 2,208,000 9.750% | 32,116 (+1.48%) | Filing History |
| 2025-02-14 5:42 pm Purchase | 2024-12-31 | 13G | Ekso Bionics Holdings, Inc. EKSO | ARMISTICE CAPITAL LLC | 2,250,021 9.990% | 57,308 (+2.61%) | Filing History |
| 2025-02-14 5:42 pm Sale | 2024-12-31 | 13G | Edible Garden AG Incorporated EDBL | ARMISTICE CAPITAL LLC | 79,793 9.990% | -2,298 (-2.80%) | Filing History |
| 2025-02-14 5:41 pm Purchase | 2024-12-31 | 13G | Dermata Therapeutics, Inc. DRMA | ARMISTICE CAPITAL LLC | 276,422 9.990% | 90,211 (+48.45%) | Filing History |
| 2025-02-14 5:41 pm Purchase | 2024-12-31 | 13G | Danimer Scientific, Inc. DNMR | ARMISTICE CAPITAL LLC | 171,761 5.500% | 171,761 (New Position) | Filing History |
| 2025-02-14 5:41 pm Purchase | 2024-12-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | ARMISTICE CAPITAL LLC | 478,547 9.990% | 70,437 (+17.26%) | Filing History |
| 2025-02-14 5:40 pm Purchase | 2024-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ARMISTICE CAPITAL LLC | 841,695 9.990% | 619,040 (+278.03%) | Filing History |
| 2025-02-14 5:39 pm Purchase | 2024-12-31 | 13G | Cosmos Health Inc. COSM | ARMISTICE CAPITAL LLC | 2,508,013 9.990% | 359,825 (+16.75%) | Filing History |
| 2025-02-14 5:38 pm Purchase | 2024-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 5,216,445 9.990% | 642,699 (+14.05%) | Filing History |
| 2025-02-14 5:36 pm Sale | 2024-12-31 | 13G | Iveda Solutions, Inc. IVDA | ARMISTICE CAPITAL LLC | 139,603 4.990% | -96,660 (-40.91%) | Filing History |